Michael E Prevoznik sold $43k of DGX
SVP & General Counsel at QUEST DIAGNOSTICS INC. 227 shares at an average of $188.13, traded Sep 26, 2025, filed Sep 30, 2025.
Score components
- +15RoleOfficer
- +6Trade size$43k at market
- 0Share of holdings soldSold 0.6% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001022079-25-000203, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 26, 2025 | MOption exercise Common Stock10b5-1 | +227 | $103.57 | $24k | 38,344 | Sep 30, 2025 |
| Sep 26, 2025 | SOpen-market sale Common Stock10b5-1 | -83 | $187.22 | $16k | 38,261 | Sep 30, 2025 |
| Sep 26, 2025 | SOpen-market sale Common Stock10b5-1 | -144 | $188.66 | $27k | 38,117 | Sep 30, 2025 |
| Sep 26, 2025 | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -227 | $103.57 | $24k | 0 | Sep 30, 2025 |
Related signals
Other insiders at QUEST DIAGNOSTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $2.4M 10,000 shares | -8% | |
| 28Weak | QUEST DIAGNOSTICS INC | Catherine T. Doherty EVP, Regional Businesses | $1.1M 5,558 shares | -8% | |
| 38Weak | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $2.1M 10,000 shares | -8% | |
| 14Weak | QUEST DIAGNOSTICS INC | Catherine T. Doherty EVP, Regional Businesses | $131k 632 shares | -1% | |
| 17Weak | QUEST DIAGNOSTICS INC | Catherine T. Doherty EVP, Regional Businesses | $294k 1,433 shares | -2% | |
| 15Weak | QUEST DIAGNOSTICS INC | Catherine T. Doherty EVP, Regional Businesses | $5.4M 26,165 shares | -28% | |
| 40Moderate | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $11M 55,093 shares | -31% | |
| 43Moderate | QUEST DIAGNOSTICS INC | Vicky B Gregg director | $240k 1,250 shares | -7% | |
| 40Moderate | QUEST DIAGNOSTICS INC | Mark E Delaney SVP & Chief Commercial Officer | $1.5M 7,946 shares | -51% | |
| 28Weak | DGXsell QUEST DIAGNOSTICS INC | Gary M Pfeiffer director | $270k 1,482 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.